State-of-the-Art Update on Long COVID: Pathogenesis Management, Clinical Trial Updates, and Patient Perspective

Last Modified: Mar 23, 2023 @ 11:59 AM

Program Description

This half-day virtual course will cover what is currently known about long COVID, including in people with HIV.

This course will include an overview of the clinical relationship between long COVID and HIV, a case-based panel discussion on the evaluation and management of long COVID, and discussions on pathogenesis and update on current clinical trials and will feature a unique long COVID patient perspective.

Assessment of Needs

Rapid advances in HIV and COVID-19 require the ongoing attention of practitioners involved in direct patient care. This course will address the implications of new information on strategies for the clinical management of long COVID in different clinical settings. Information will be presented through a mix of didactic lectures, clinically relevant cases, and a roundtable discussion developed and led by an expert faculty of HIV/AIDS and COVID-19 clinicians and researchers.

Topics

• Patient Perspective: Long COVID
• Pathogenesis of Long COVID
• Evaluation and Management of Long COVID (case-based)
• Long COVID and HIV
• Long COVID Clinical Trials

Conflicts of Interest

In the interest of maintaining the independence of its continuing education activities, and in accordance with the policies of the Accreditation Council for Continuing Medical Education (ACCME), the IAS–USA requires all persons with control of content (eg, faculty, IAS–USA Board members, and program staff) to disclose any financial relationships with ineligible companies (previously defined as “commercial interests”) that they or their spouses or partners have had within the past 24 months. Any real or apparent conflicts of interest of those parties are resolved prior to the continuing education activity being delivered. Individuals who refuse to disclose financial interests may not participate in an IAS–USA continuing education activity.

The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Registration

Who Should Attend

This course is designed for physicians who are actively involved in the medical care of people with HIV or COVID-19 and:

• Provide comprehensive or specialty care for patients with HIV
• Provide outpatient or inpatient care for patients with COVID-19
• Are currently active in HIV or COVID-19 research

This activity is also relevant to nurse practitioners, registered nurses, physician assistants, registered pharmacists, and other health professionals.

Representatives and employees of commercial companies (eg, pharmaceutical, diagnostic, medical products, advertising, insurance, investment, and communications firms) must contact the IAS–USA regarding registration procedures.

Cancellation Policy

Cancellation requests must be made 8 or more days before the date of an activity. All refunds will be processed minus a $15.00 processing charge. Regrettably, any cancellation requests received within a week before the course will not be eligible for the partial refund.

Continuing Education Credits

CME Credits

The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The IAS–USA designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC Points